Veeral Desai, Chief Strategy & Development Officer at agilon health, inc. (AGL), sold 4,500 shares at $26.15 ($118K) on 2023-05-09, disclosed to the SEC on 2023-05-11.
Scheduled sale ($118k) by Chief Strategy & Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AGL | SELL | 2023-03-17 | $1.6M | — | Filing → |
| AGL | SELL | 2022-07-25 | $2.2M | — | Filing → |
| AGL | SELL | 2022-07-11 | $8.0M | — | Filing → |